Scarica l'app Stockscreener
670.21
0.18%
1.21
Dopo l'orario di chiusura:
670.40
0.19
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$669.00
Aprire:
$670.18
Volume 24 ore:
574.10K
Relative Volume:
1.26
Capitalizzazione di mercato:
$21.35B
Reddito:
$4.17B
Utile/perdita netta:
$1.03B
Rapporto P/E:
53.13
EPS:
12.6148
Flusso di cassa netto:
$940.22M
1 W Prestazione:
-5.93%
1M Prestazione:
+5.48%
6M Prestazione:
+29.36%
1 anno Prestazione:
+59.64%
Intervallo 1D:
$665.25
$681.63
Intervallo di 1 settimana:
$665.25
$719.25
Portata 52W:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
670.21 | 53.42B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
576.03 | 213.09B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
225.51 | 155.71B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
143.84 | 40.97B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
MTD
Mettler Toledo International Inc
|
1,396.45 | 28.37B | 3.87B | 829.75M | 847.84M | 39.48 |
|
WAT
Waters Corp
|
376.63 | 22.50B | 2.91B | 622.64M | 620.14M | 10.48 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Why IDEXX Laboratories Inc. stock is a must watch in 20252025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Can IDEXX Laboratories Inc. (IX1) stock retain market dominanceWeekly Gains Report & Risk Controlled Stock Pick Alerts - newser.com
Will IDEXX Laboratories Inc. stock outperform growth indexesJuly 2025 Retail & Technical Confirmation Trade Alerts - newser.com
Why IDEXX Laboratories Inc. stock could benefit from AI revolutionJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Is IDEXX Laboratories Inc. stock cheap at current valuation2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
Is IDEXX Laboratories Inc. stock attractive for ETFsTrend Reversal & Reliable Entry Point Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Is IDEXX Laboratories Inc. stock trading at a premium valuation2025 Price Targets & Low Drawdown Investment Strategies - newser.com
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedJobs Report & Precise Swing Trade Alerts - newser.com
IDEXX Laboratories (IDXX) Price Target Increased by 10.84% to 773.18 - Nasdaq
Quantitative breakdown of IDEXX Laboratories Inc. recent moveMarket Weekly Review & Reliable Volume Spike Trade Alerts - newser.com
What machine learning models say about IDEXX Laboratories Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
Is IDEXX Laboratories Inc. stock supported by strong cash flows - newser.com
Does IDEXX Laboratories Inc. fit your quant trading modelMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Is IDEXX Laboratories Inc. (IX1) stock prepared for digital transitionTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com
Will IDEXX Laboratories Inc. stock recover after recent dropEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Trend analysis for IDEXX Laboratories Inc. this weekJuly 2025 Recap & Growth Focused Stock Reports - newser.com
IDEXX Laboratories Amends Credit Agreement for Flexibility - TipRanks
Building trade automation scripts for IDEXX Laboratories Inc.2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Idexx Laboratories Shares Reach New Highs Amid Insider Selling Activity - AD HOC NEWS
Insider Move: Nimrata Hunt Exercises Options, Realizing $4.10M At IDEXX Laboratories - Benzinga
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing - MarketScreener
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.63 Million in Common Stock - 富途牛牛
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.60%
3.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):